Earn a 4.1% p.a. portfolio yield with low-risk Income Investing! Click to learn more.

We’re licensed by the Monetary Authority of Singapore (Licence no.&nbsp;<a href="https://eservices.mas.gov.sg/fid/institution/detail/201134-ASIA-WEALTH-PLATFORM-PTE-LTD">CMS100604</a>).

Insights

We’re licensed by the Securities and Futures Commission of Hong Kong (<a></a><a href="https://apps.sfc.hk/publicregWeb/corp/BQE542/details" target="_blank">CE No. BQE542</a>)

We’re licensed by the Securities Commission Malaysia (Licence <a href="https://easy.seccom.com.my:8222/entityprofile/1ca93ae1-4c0e-4c55-90e0-1850600e54f6">eCMSL/A0352/2018</a>)

We’re licensed by the Securities and Exchange Commission (License no.&nbsp;<a></a><a href="https://market.sec.or.th/public/idisc/en/companyprofile/Intermediaries/0000031407" target="_blank">Lor Khor-0136-01</a>).

StashAway Management (DIFC) Limited is regulated by the DFSA (license number&nbsp;<a href="https://www.dfsa.ae/public-register/firms/stashaway-management-difc-limited">F006312</a>).

We discuss the US-China trade deal and Singapore's industrial production numbers

Market Commentary: 26 August 2020

Volatility can strike at any time in any asset class. Diversification helps prepare you for it.

Stay Focused on Diversification Even as Markets Rebound

We discuss how the Fed's monetary stimuli impact the US dollar and the S&P 500's performance

Market Commentary: 19 August 2020

We discuss the US virus relief bill, Hong Kong's security law, and the Russian vaccine

Market Commentary: 12 August 2020

We discuss TikTok's predicament in the US, and the virus relief bill.

Market Commentary: 5 August 2020

It’s more than just your risk tolerance. It’s also how your life circumstances and your goals add up.

What’s Your Risk Profile?

We discuss the Fed's latest meeting and how the US stimulus package is shaping up

Market Commentary: 29 July 2020

Taking your financial future even further with $16 million USD in new funding

We’ve Raised Another $16 Million USD in New Funding

We discuss the European stimulus package and vaccine trials.

Market Commentary: 22 July 2020

We discuss Moderna's vaccine trials, and political tensions between the US and China